Secret-AAR

Secret-AAR predicts and analyzes the secretome of Mycobacterium abscessus (MAB) clinical isolates to characterize excreted and secreted (ES) proteins relevant to antigenicity, virulence, and potential therapeutic targets.


Key Features:

  • Comprehensive secretome prediction: Predicts secretomes for the reference strain ATCC 19977 and fifteen clinical isolates across the three MAB subspecies: M. abscessus subsp. abscessus, M. abscessus subsp. bolletii, and M. abscessus subsp. massiliense.
  • Antigenic analysis: Identifies ES proteins with high antigenic densities and reports higher antigenic density and larger predicted secretomes for rough (R) versus smooth (S) colony morphotypes.
  • Comparative secretome profiling: Reports that approximately 18% of encoded proteins are predicted as secreted and that over 85% of predicted secreted proteins are shared among the three subspecies.
  • Homology to M. tuberculosis secretome: Identifies 337 ES proteins with homologues in Mycobacterium tuberculosis secretomes, including 222 proteins with experimental support for secretion.
  • Drug-target homology mapping: Notes that some predicted ES proteins show homology to known drug targets listed in the DrugBank database.
  • Pathogenicity-associated domains: Indicates a higher abundance of proteins related to quorum-sensing and Mce domains in MAB compared to the Mycobacterium tuberculosis complex (MTBC).
  • Essential gene correlation: Cross-references the ATCC 19977 predicted secretome with essential genes and identifies 99 secreted proteins required for in vitro growth.

Scientific Applications:

  • Vaccine and diagnostic development: Prioritizes highly antigenic ES proteins for design of diagnostic assays and vaccine candidates against MAB.
  • Therapeutic target discovery: Facilitates identification of secreted proteins homologous to known DrugBank targets for therapeutic exploration.
  • Pathogenicity research: Supports investigation of quorum-sensing and Mce domain-associated proteins to elucidate MAB virulence mechanisms.

Methodology:

Integrates genomic data analysis, protein prediction algorithms, and comparative genomics for secretome characterization.

Topics

Details

Added:
1/18/2021
Last Updated:
2/13/2021

Operations

Publications

Cornejo-Granados F, Kohl TA, Sotomayor FV, Andres S, Hernández-Pando R, Hurtado-Ramírez JM, Utpatel C, Niemann S, Maurer FP, Ochoa-Leyva A. <i>In silico</i>secretome characterization of clinical<i>Mycobacterium abscessus</i>isolates provides insights into antigenic differences. Unknown Journal. 2020. doi:10.1101/2020.10.22.349720.